CLINICAL_TRIALS
trial_result
· 2021-09-08
Clinical Trial Update: A Study of ALKS 3831 in Adults With Schizophrenia [Phase 2]
Summary
Phase 2 trial update for ALKS 3831 in adults with schizophrenia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alkermes, Inc. | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2021-09-08